Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Johnson and Johnson
Chinese Patent Office

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 014901

« Back to Dashboard

NDA 014901 describes KENALOG-40, which is a drug marketed by Apothecon and is included in one NDA. It is available from eleven suppliers. Additional details are available on the KENALOG-40 profile page.

The generic ingredient in KENALOG-40 is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Pharmacology for NDA: 014901
Medical Subject Heading (MeSH) Categories for 014901
Suppliers and Packaging for NDA: 014901
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KENALOG-40 triamcinolone acetonide INJECTABLE;INJECTION 014901 NDA E.R. Squibb & Sons, L.L.C. 0003-0293 0003-0293-05 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-0293-05) > 1 mL in 1 VIAL, SINGLE-DOSE
KENALOG-40 triamcinolone acetonide INJECTABLE;INJECTION 014901 NDA E.R. Squibb & Sons, L.L.C. 0003-0293 0003-0293-28 1 VIAL, MULTI-DOSE in 1 CARTON (0003-0293-28) > 10 mL in 1 VIAL, MULTI-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength40MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.